Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on whatsapp
WhatsApp

letrozole

Femara®, letrozole, is anti cancer drug, a form of hormone therapy known as an aromatase inhibitor, which works by reducing the amount of estrogen in postmenopausal women.
This medicine is a hormonal (or “endocrine”) breast cancer treatment. Growth of breast cancer is frequently stimulated by oestrogens, which are female sex hormones. Femara reduces the amount of oestrogen by blocking an enzyme (“aromatase”) involved in the production of oestrogens and may therefore block the growth of breast cancers that need oestrogen to grow. As a consequence, tumour cells slow down or stop growing and/or spreading to other parts of the body.

Indications:

To Read More>>

To get a personal free assessment to our service please in fill in your details and we will get back to you shortly

Improve therapeutic outcomes, prolong life and quality of life, are our main business.
We support access to and expand cancer treatments beyond the standard of care, with the most advanced and innovative treatment options in the world, personally matching the individual cancer patient’s medical condition and with the support of top tier oncologists.

Article categories

קטגוריות המאמרים

Popular topics